Bavarian Nordic A/S
OTC:BVNKF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bavarian Nordic A/S
OTC:BVNKF
|
DK |
|
E
|
Eonx Technologies Inc
CNSX:EONX
|
AU |
|
P
|
PlasCred Circular Innovations Inc
CNSX:PLAS
|
CA |
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
DK |
|
C
|
Chubu Electric Power Co Inc
SWB:0C2
|
JP |
Intrinsic Value
Is BVNKF undervalued or overvalued?
See the intrinsic value estimate for Bavarian Nordic A/S and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
BVNKF looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with BVNKF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Bavarian Nordic A/S Does
Bavarian Nordic is a vaccine company that develops, makes, and sells vaccines for infectious diseases. Its best-known products are vaccines for smallpox and mpox, rabies, and tick-borne encephalitis, along with a few other travel and specialty vaccines. It also works on vaccine candidates for other diseases and immune-related medicines, but its core business is finished vaccines rather than general drug development.
- Headquarters
- Denmark DK
- Employees
- 1 861
- IPO date
- Nov 2, 1998
Revenue & Expenses Breakdown
Bavarian Nordic A/S
Earnings Waterfall
Bavarian Nordic A/S
The intrinsic value for Bavarian Nordic A/S (BVNKF) under the Base Case is hidden USD.
Compared with the current market price of 36.06 USD, the stock appears hidden.